A Case of Exacerbation of Subclinical Hyperthyroidism after First Administration of BNT162b2 mRNA COVID-19 Vaccine

COVID-19 vaccines are the most critical measure for controlling the COVID-19 pandemic; however, we have little information on their complications. We experienced a case of a patient who developed hyperthyroidism complicated with atrial fibrillation and heart failure on the sixth day after the first...

Full description

Saved in:
Bibliographic Details
Published inVaccines (Basel) Vol. 9; no. 10; p. 1108
Main Authors Yamamoto, Kana, Mashiba, Takahisa, Takano, Keisuke, Suzuki, Toshihiko, Kami, Masahiro, Takita, Morihito, Kusumi, Eiji, Mizuno, Yasuhiro, Hamaki, Tamae
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 29.09.2021
MDPI
Subjects
Autoimmune diseases
Cardiac arrhythmia
Case Report
Complications
Congestive heart failure
Coronaviruses
COVID-19
COVID-19 vaccines
Diabetes
Disease
Drug dosages
Edema
Emergency medical care
Fever
Fibrillation
Graves’ disease
Heart failure
Hormones
Hyperthyroidism
Iodine
mRNA
Myocarditis
Obesity
Pain
Pandemics
Patients
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Thrombocytopenia
Thrombosis
Thyroid gland
Ultrasonic imaging
vaccination
vaccine
Vaccines
Japan
COVID-19
heart failure
SARS-CoV-2
subclinical hyperthyroidism
vaccine
Graves’ disease
vaccination
Online AccessGet full text

Cover

More Information
Summary:COVID-19 vaccines are the most critical measure for controlling the COVID-19 pandemic; however, we have little information on their complications. We experienced a case of a patient who developed hyperthyroidism complicated with atrial fibrillation and heart failure on the sixth day after the first dose of COVID-19 vaccination. This case report shows the importance of considering hyperthyroidism as a possible complication after COVID-19 vaccination.
ISSN:2076-393X
2076-393X
DOI:10.3390/vaccines9101108